Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2003
12/10/2003EP1369037A1 Synergistic preparations based on mixtures of glycerol ether with aromatic alcohol for controlling mycobacteria
12/10/2003EP1368473A2 Neurotransmission-associated proteins
12/10/2003EP1368470A2 Transcriptional mediators of blood vessel development and endothelial differentiation
12/10/2003EP1368454A1 Method for detecting a risk of hypertension and uses thereof
12/10/2003EP1368381A1 2-alkylated-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block
12/10/2003EP1368378A2 Constitutively desensitized g protein-coupled receptors
12/10/2003EP1368371A2 Transfection complexes
12/10/2003EP1368365A2 C2,5'-disubstituted and n6,c2,5'-trisubstituted adenosine derivatives and their different uses
12/10/2003EP1368364A1 C2, 8-disubstituted adenosine derivatives and their different uses
12/10/2003EP1368358A1 Isoxazoline derivatives as anti-depressants
12/10/2003EP1368357A1 Tricyclic quinolinone and tricyclic quinoline as androgen receptor modulator compounds
12/10/2003EP1368356A2 N-but-3-enyl norbuprenorphine and its use as analgesic
12/10/2003EP1368355A2 Substituted pyrazolopyrimidines and thiazolopyrimidines
12/10/2003EP1368354A1 Modulators of chemokine receptor activity
12/10/2003EP1368353A1 2-alkoxyphenyl substituted imidazotriazinones
12/10/2003EP1368352A1 Cyclic guanosine 3',5'-monophosphate phosphodiesterase inhibitors
12/10/2003EP1368350A1 Novel crystal forms of 9-substituted hypoxanthine derivatives
12/10/2003EP1368349A1 Xanthine derivative, production and use thereof as a medicament
12/10/2003EP1368348A1 Novel 2,5-diazabicyclo(2.2.1)heptane derivatives
12/10/2003EP1368346A1 Substituted benzofuran-2-carboxamides derivatives
12/10/2003EP1368345A1 Alkoxycarbonylamino heteroaryl carboxylic acid derivatives as ip antagonists
12/10/2003EP1368344A1 Piperazine derivatives, their preparation and uses in therapy (5ht1b receptor activity)
12/10/2003EP1368343A1 1-(2-methoxybenzyl)-3-benzhydrylpiperazines as tachykinin antagonists
12/10/2003EP1368342A2 Benzimidazole and pyridylimidazole derivatives as ligands for gaba receptors
12/10/2003EP1368341A1 Phenyl derivatives 3
12/10/2003EP1368340A1 Piperazine derivatives as melanocortin receptor agonists
12/10/2003EP1368339A1 Substituted piperidines/piperazines as melanocortin receptor agonists
12/10/2003EP1368338A1 Method of preparing lansoprazole and its intermediate
12/10/2003EP1368337A2 Piperazine derivatives and their use as 5-ht1b ligands
12/10/2003EP1368336A2 Thiophene substituted amine derivatives as glyt-1 inhibitors
12/10/2003EP1368335A2 Novel amino dicarboxylic acid derivatives with pharmaceutical properties
12/10/2003EP1368330A1 Process for the preparation of citalopram
12/10/2003EP1368328A1 Methods for preparing new taxoids and pharmaceutical compositions containing them
12/10/2003EP1368327A1 Benzo thiadiazine matrix metalloproteinase inhibitors
12/10/2003EP1368324A1 Quinazolines as mmp-13 inhibitors
12/10/2003EP1368323A1 Pyrimidine matrix metalloproteinase inhibitors
12/10/2003EP1368322A2 New crystal forms of oxcarbazepine and processes for their preparation
12/10/2003EP1368321A1 Anti-malarial compounds
12/10/2003EP1368320A1 Substituted 2-oxy-3,5-dicyano-4-aryl-6-aminopyridines and use thereof
12/10/2003EP1368319A1 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and their use as adenosine receptor-selective ligands
12/10/2003EP1368318A2 Calcilytic compounds
12/10/2003EP1368317A1 Tryptase inhibitors
12/10/2003EP1368314A1 N-4-piperidinyl compounds as ccr5 modulators
12/10/2003EP1368313A1 Method for producing non-hydrated fexofenadine hydrochloride and a novel crystalline form obtained thereby
12/10/2003EP1368312A1 Benzo'f!isoindole derivatives with affinity to the ep4 receptor
12/10/2003EP1368309A2 Thiol-modified hyaluronan
12/10/2003EP1368308A1 Cannabinoid receptor ligands
12/10/2003EP1368306A1 Novel 1,2-diphenylethene derivatives for treatment of immune diseases
12/10/2003EP1368305A1 7, 9-substituted tetracycline compounds
12/10/2003EP1368304A1 Prodrugs of excitatory amino acids
12/10/2003EP1368303A1 Halogen-substituted amino dicarboxylic acid derivatives as medicaments for treating cardiovascular diseases
12/10/2003EP1368302A1 Novel amino dicarboxylic acid derivatives
12/10/2003EP1368301A1 Side-chain halogenated amino carboxylic acid derivatives as medicaments for treating cardiovascular diseases
12/10/2003EP1368300A1 Substituted amino dicarboxylic acid derivatives
12/10/2003EP1368299A2 Substituted c-cyclohexylmethylamine derivatives
12/10/2003EP1368296A1 Fluorinated trienes and their use as rxr modulators
12/10/2003EP1368253A1 Inhaler with means for improving chemical stability of medicinal aerosol solution contained therein
12/10/2003EP1368094A1 4-(2-butylamino)-2,7-dimethyl-8-(2-methyl-6-methoxypyrid-3-yl) pyrazolo- 1,5-a]-1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands
12/10/2003EP1368063A2 Complex of modafinil and cyclodextrin
12/10/2003EP1368056A1 Recombinant gelatin-like proteins for use as plasma expanders
12/10/2003EP1368054A2 Using neural thread proteins to treat tumors and other hyperproliferative disorders
12/10/2003EP1368048A1 Pharmaceutical composition made of cannabis extracts
12/10/2003EP1368046A1 Pharmaceutical formulation and the use thereof for preparing a medicament for the treatment of cardiovascular diseases
12/10/2003EP1368041A1 Amphotericin b aqueous composition
12/10/2003EP1368040A2 Use of 5-substituted nucleosides and/or prodrugs thereof in the resistance-free treatment of infectious diseases
12/10/2003EP1368039A2 Aminoglycoside treatment for lysosomal storage diseases
12/10/2003EP1368038A1 Methods for the administration of amifostine and related compounds
12/10/2003EP1368037A2 Estrogen replacement therapy
12/10/2003EP1368036A1 Regulation of glucocorticoid concentration
12/10/2003EP1368035A1 Use of type 4 phosphodiesterase inhibitors in myocardial diseases
12/10/2003EP1368034A1 Method and dosage form for treating tumors by the administration of tegafur, uracil, folinic acid, paclitaxel and carboplatin
12/10/2003EP1368033A2 Method and apparatus for treating breakthrough pain
12/10/2003EP1368032A1 Excitatory amino acid receptor antagonists
12/10/2003EP1368031A2 Method of treating of demyelinating diseases or conditions
12/10/2003EP1368030A1 Epothilone derivatives for the treatment of refractory tumors
12/10/2003EP1368029A2 Method and composition for rejuvinating cells, tissues, organs, hair and nails
12/10/2003EP1368028A1 Benzimidazole compounds for modulating ige and inhibiting cellular proliferation
12/10/2003EP1368027A2 Use of tryptophan derivatives for the specific cytostatic treatment of serotonin-producing tumors
12/10/2003EP1368026A1 Use of active substance combinations from alpha lipoic acid and substances that absorb light in the uv-a and/or uv-b range for use in the treatment and/or prophylaxis of undesired cutaneous pigmentation
12/10/2003EP1368025A2 Compositions useful for the treatment of pathologies responding to the activation of ppar-gamma receptor
12/10/2003EP1368024A1 Treatment of restenosis
12/10/2003EP1368023A1 Utilization of buprenorphine in urinary incontinence therapy
12/10/2003EP1368022A1 Device for packaging an oxiplatinum solution
12/10/2003EP1368021A1 Carbamate compounds for use in preventing or treating bipolar disorder
12/10/2003EP1368020A2 Method for identifying maxi-k channel blockers
12/10/2003EP1368019A1 Esmolol formulation
12/10/2003EP1368018A2 Use of sugar phosphate, sugar phosphate analogues, amino acids and/or amino acid analogues for modulating the glycolysis-enzyme complex, the malate-aspartate shuttle and/or transaminases
12/10/2003EP1368017A2 Compositions of biochemical compounds involved in bioenergy metabolism of cells and method of use
12/10/2003EP1368016A1 Parenteral dosage forms comprising a suspension of tramadol salt and diclofenac salt
12/10/2003EP1368015A1 Use of accelerated lymphocyte homing agents for the manufacture of a medicament for the treatment of delayed graft function
12/10/2003EP1368014A1 Use of cyclohexenone derivatives for the manufacture of a medicament in the treatment of dysuria
12/10/2003EP1368013A1 Use of a cyclohexenone derivatives in the manufacture of a medicament for treating diabetic complications
12/10/2003EP1368012A2 Use of one or more shogaol(s) as an aphrodisiac
12/10/2003EP1368010A2 Antibacterial compositions which contain oxapenem-3-carboxylic acids and antibiotics
12/10/2003EP1368009A2 Aldosterone blocker therapy to prevent or treat inflammation-related disorders
12/10/2003EP1368008A1 Transdermal therapeutic system for the administration of partial dopamine-d2 agonists
12/10/2003EP1368006A1 Novel modified released formulation
12/10/2003EP1368005A2 Chronotherapeutic dosage forms
12/10/2003EP1368004A2 Mucoadhesive dispersible pharmaceutical preparation for active-agent dosing in veterinary and human medicine
12/10/2003EP1368003A1 Methods and compositions for reducing the taste of pharmaceutically active agents
1 ... 5248 5249 5250 5251 5252 5253 5254 5255 5256 5257 5258 5259 5260 5261 5262 5263 5264 5265 5266 5267 5268 ... 7860